Literature DB >> 21518964

Tacrolimus-induced hypertension: what's endothelial and hematopoietic FKBP12 got to do with it?

Sean P Didion.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21518964      PMCID： PMC3133445          DOI： 10.1161/HYPERTENSIONAHA.111.172320

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.

Authors:  Valorie L Chiasson; Deepa Talreja; Kristina J Young; Piyali Chatterjee; Amy K Banes-Berceli; Brett M Mitchell
Journal:  Hypertension       Date:  2011-04-25       Impact factor: 10.190

2.  Mechanisms of FK 506-induced hypertension in the rat.

Authors:  Y Takeda; I Miyamori; K Furukawa; S Inaba; H Mabuchi
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

3.  Stat3 mediates interleukin-6 [correction of interelukin-6] inhibition of human endothelial nitric-oxide synthase expression.

Authors:  Marta Saura; Carlos Zaragoza; Clare Bao; Beatriz Herranz; M Rodriguez-Puyol; Charles J Lowenstein
Journal:  J Biol Chem       Date:  2006-08-03       Impact factor: 5.157

4.  The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Authors:  M J Tocci; D A Matkovich; K A Collier; P Kwok; F Dumont; S Lin; S Degudicibus; J J Siekierka; J Chin; N I Hutchinson
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

5.  Arterial hypertension and renal allograft survival.

Authors:  K C Mange; B Cizman; M Joffe; H I Feldman
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

6.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  P L Huang; Z Huang; H Mashimo; K D Bloch; M A Moskowitz; J A Bevan; M C Fishman
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

7.  IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy.

Authors:  Laura I Schrader; Dale A Kinzenbaw; Andrew W Johnson; Frank M Faraci; Sean P Didion
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-25       Impact factor: 8.311

8.  Hypertension after kidney transplantation.

Authors:  Bertram L Kasiske; Shakeel Anjum; Rajiv Shah; Jeffrey Skogen; Chitra Kandaswamy; Barbara Danielson; Eileen A O'Shaughnessy; David C Dahl; John R Silkensen; Meena Sahadevan; Jon J Snyder
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

9.  A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.

Authors: 
Journal:  N Engl J Med       Date:  1994-10-27       Impact factor: 91.245

10.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190
  10 in total
  2 in total

1.  Adult Renal Transplantation in a Patient 28 Years after Heart Transplantation as a Neonate for Hypoplastic Left Heart Syndrome.

Authors:  Joseph Licata; Shane Michael Roberts; Piotr Janicki; Dmitri Bezinover
Journal:  Case Rep Transplant       Date:  2022-04-05

2.  Inferior outcomes following cardiac surgery in patients with a functioning renal allograft.

Authors:  Ibrahim T Fazmin; Muhammad U Rafiq; Samer Nashef; Jason M Ali
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.